Description
An orally available, selective VEGFR inhibitor (IC50s = 0.21, 0.16, and 0.24 nM for VEGFR1, VEGFR2, and VEGFR3, respectively); also inhibits c-Kit and PDGFRβ (IC50s = 1.63 and 1.72 nM, respectively)
Formal name: N-[2-chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N’-(5-methyl-3-isoxazolyl)-urea, monohydrate
Synonyms: AV-951|KRN 951
Molecular weight: 472.9
CAS: 682745-40-0
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|PDGFR Family||Product Type|Biochemicals|Kinase Inhibitors|VEGFR Family||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Angiogenesis||Research Area|Cancer|Cell Signaling|Growth Factor Receptor Signaling